Company intelligence / Profile preview

CenExel

Salt Lake City, Utah, United Statesfacebook.com ↗

Ownership: Private
Employees: ~1200
Development stage: Commercial

Overview

CenExel is one of the largest U.S. networks of clinical research sites specializing in complex and high-unmet need therapeutic areas such as CNS disorders. The company has supported over 10,000 trials involving more than 100,000 patients and offers deep expertise in protocol design/execution, patient recruitment/retention strategies—including digital tools—and operational excellence. It is recognized for scientific rigor and high-quality data delivery.

Therapeutic areas: OtherPsychiatryNeurology
Modalities: Small moleculeBiologicMonoclonal antibodyCell therapyGene therapy
Industry: Contract Research Organization

Partnerships

Leading pharmaceutical companies and biotechs on sponsored trials

Beyond the preview

Go deeper on CenExel.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CenExel.

Explore the full profile